<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbed13734-tbl-0004" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
 <label>TABLE 4</label>
 <caption>
  <p>Principle molecular targets of SARS‐CoV‐2 for drug discovery or design</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Viral cycle</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Molecular targets</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Potential anti‐viral drugs</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="5" colspan="1">Host attachment and entry</td>
    <td align="left" rowspan="1" colspan="1">Host cell serine protease receptor</td>
    <td align="left" rowspan="1" colspan="1">Eriodictyol, Cepharanthine, Ergoloid, Nitrofurantoin</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Host tyrosine kinase receptor</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">ACE2
     <xref ref-type="fn" rid="tbed13734-note-0003">*</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Integrins</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Spike protein
     <xref ref-type="fn" rid="tbed13734-note-0003">*</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">EK1C4</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Uncoating</td>
    <td align="left" rowspan="1" colspan="1">Ion channel proteins</td>
    <td align="left" rowspan="1" colspan="1">Amantadine</td>
   </tr>
   <tr>
    <td align="left" rowspan="2" colspan="1">Replicase Protein Expression</td>
    <td align="left" rowspan="1" colspan="1">Papain‐like proteinase (PLpro)</td>
    <td align="left" rowspan="1" colspan="1">Mycophenolic acid, Grazoprevir, Formoterol, Telaprevir, Diarylheptanoids, etc</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">3C‐like main protease (3CLpro)
     <xref ref-type="fn" rid="tbed13734-note-0003">*</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Ritonavir, Nelfinavir, Lopinavir, Ebselen, Cinanserin, Ketoamide, Atazanavir,</td>
   </tr>
   <tr>
    <td align="left" rowspan="4" colspan="1">Replication of viral genome</td>
    <td align="left" rowspan="1" colspan="1">RNA‐dependent RNA polymerase (RdRp)
     <xref ref-type="fn" rid="tbed13734-note-0003">*</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Remdesivir, Baloxavir marboxil, Triazavirin, Favipiravir (Avigan), Ribavirin, Penciclovir, Acyclovir fleximer analogue, Galidesivir</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Helicase</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">The peptidyl/prolyl isomerases (PPIases)</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Nucleoside analogues</td>
    <td align="left" rowspan="1" colspan="1">Remdesivir, Favipiravir, ribavirin, 5‐fluorouracil</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Viral protein assembly</td>
    <td align="left" rowspan="1" colspan="1">Envelope protein (protein E)</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Cell release of the virus</td>
    <td align="left" rowspan="1" colspan="1">ORF7a</td>
    <td align="left" rowspan="1" colspan="1">ND</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="tbed13734-ntgp-0002">
  <fn id="tbed13734-note-0002">
   <p>Abbreviation: ND, not determined.</p>
  </fn>
  <fn id="tbed13734-note-0003">
   <label>*</label>
   <p>Indicates the sofar principle targets.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
  <license>
   <license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
  </license>
 </permissions>
</table-wrap>
